Number of the records: 1

oblasť imunoglobulínov, variabilná

	MeSH Tree Structures - oblasť imunoglobulínov, variabilná `[d12.644.541.500.650.500]` aminokyseliny, peptidy a proteíny [d12] + peptidy [d12.644] + fragmenty peptidové [d12.644.541] + fragmenty imunoglobulínov [d12.644.541.500] + Fab fragmenty imunoglobulínov [d12.644.541.500.650] + abciximab [d12.644.541.500.650.125] certolizumab pegol [d12.644.541.500.650.250] oblasť imunoglobulínov, variabilná `[d12.644.541.500.650.500]` oblasti určujúce komplementárnosť [d12.644.541.500.650.500.180] oblasť imunoglobulínov, väzbová [d12.644.541.500.650.500.590] protilátky jednoreťazcové [d12.644.541.500.650.500.800] protilátky jednodoménové [d12.644.541.500.650.500.900] tuftsín [d12.644.541.500.650.750]
	`[d12.776.124.486.485.680.650.500]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + proteíny krvné [d12.776.124] + imunoproteíny [d12.776.124.486] + imunoglobulíny [d12.776.124.486.485] + fragmenty imunoglobulínov [d12.776.124.486.485.680] + Fab fragmenty imunoglobulínov [d12.776.124.486.485.680.650] + abciximab [d12.776.124.486.485.680.650.125] certolizumab pegol [d12.776.124.486.485.680.650.250] oblasť imunoglobulínov, variabilná `[d12.776.124.486.485.680.650.500]` oblasti určujúce komplementárnosť [d12.776.124.486.485.680.650.500.180] oblasť imunoglobulínov, väzbová [d12.776.124.486.485.680.650.500.590] protilátky jednoreťazcové [d12.776.124.486.485.680.650.500.800] protilátky jednodoménové [d12.776.124.486.485.680.650.500.900] tuftsín [d12.776.124.486.485.680.650.750]
	`[d12.776.124.486.485.797]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + proteíny krvné [d12.776.124] + imunoproteíny [d12.776.124.486] + imunoglobulíny [d12.776.124.486.485] + protilátky [d12.776.124.486.485.114] + CD83 antigén [d12.776.124.486.485.256] gama-globulíny [d12.776.124.486.485.397] + oblasti imunogobulínov, konštantné [d12.776.124.486.485.538] + fragmenty imunoglobulínov [d12.776.124.486.485.680] + podjednotky imunoglobulínov [d12.776.124.486.485.705] + oblasť imunoglobulínov, variabilná `[d12.776.124.486.485.797]` oblasti určujúce komplementárnosť [d12.776.124.486.485.797.180] oblasť imunoglobulínov, väzbová [d12.776.124.486.485.797.590] paraproteíny [d12.776.124.486.485.900] +
	`[d12.776.124.790.651.680.650.500]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + proteíny krvné [d12.776.124] + globulíny sérové [d12.776.124.790] + imunoglobulíny [d12.776.124.790.651] + fragmenty imunoglobulínov [d12.776.124.790.651.680] + Fab fragmenty imunoglobulínov [d12.776.124.790.651.680.650] + abciximab [d12.776.124.790.651.680.650.125] certolizumab pegol [d12.776.124.790.651.680.650.250] oblasť imunoglobulínov, variabilná `[d12.776.124.790.651.680.650.500]` oblasti určujúce komplementárnosť [d12.776.124.790.651.680.650.500.180] oblasť imunoglobulínov, väzbová [d12.776.124.790.651.680.650.500.590] protilátky jednoreťazcové [d12.776.124.790.651.680.650.500.800] protilátky jednodoménové [d12.776.124.790.651.680.650.500.900] tuftsín [d12.776.124.790.651.680.650.750]
	`[d12.776.124.790.651.797]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + proteíny krvné [d12.776.124] + globulíny sérové [d12.776.124.790] + imunoglobulíny [d12.776.124.790.651] + protilátky [d12.776.124.790.651.114] + CD83 antigén [d12.776.124.790.651.256] gama-globulíny [d12.776.124.790.651.397] + oblasti imunogobulínov, konštantné [d12.776.124.790.651.538] + fragmenty imunoglobulínov [d12.776.124.790.651.680] + podjednotky imunoglobulínov [d12.776.124.790.651.705] + oblasť imunoglobulínov, variabilná `[d12.776.124.790.651.797]` oblasti určujúce komplementárnosť [d12.776.124.790.651.797.180] oblasť imunoglobulínov, väzbová [d12.776.124.790.651.797.590] paraproteíny [d12.776.124.790.651.900] + receptory B-buniek, antigénové [d12.776.124.790.651.950] +
	`[d12.776.377.715.548.680.650.500]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + globulíny [d12.776.377] + globulíny sérové [d12.776.377.715] + imunoglobulíny [d12.776.377.715.548] + fragmenty imunoglobulínov [d12.776.377.715.548.680] + Fab fragmenty imunoglobulínov [d12.776.377.715.548.680.650] + abciximab [d12.776.377.715.548.680.650.125] certolizumab pegol [d12.776.377.715.548.680.650.250] oblasť imunoglobulínov, variabilná `[d12.776.377.715.548.680.650.500]` oblasti určujúce komplementárnosť [d12.776.377.715.548.680.650.500.180] oblasť imunoglobulínov, väzbová [d12.776.377.715.548.680.650.500.590] protilátky jednoreťazcové [d12.776.377.715.548.680.650.500.795] protilátky jednodoménové [d12.776.377.715.548.680.650.500.897] tuftsín [d12.776.377.715.548.680.650.750]
	`[d12.776.377.715.548.797]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + globulíny [d12.776.377] + globulíny sérové [d12.776.377.715] + imunoglobulíny [d12.776.377.715.548] + protilátky [d12.776.377.715.548.114] + CD83 antigén [d12.776.377.715.548.256] gama-globulíny [d12.776.377.715.548.397] + oblasti imunogobulínov, konštantné [d12.776.377.715.548.538] + fragmenty imunoglobulínov [d12.776.377.715.548.680] + podjednotky imunoglobulínov [d12.776.377.715.548.705] + oblasť imunoglobulínov, variabilná `[d12.776.377.715.548.797]` oblasti určujúce komplementárnosť [d12.776.377.715.548.797.180] oblasť imunoglobulínov, väzbová [d12.776.377.715.548.797.590] paraproteíny [d12.776.377.715.548.900] + receptory B-buniek, antigénové [d12.776.377.715.548.950] +
	`[g02.111.570.060.425]` javy chemické [g02] + javy biochemické [g02.111] + štruktúra molekulová [g02.111.570] + sekvencia aminokyselín [g02.111.570.060] + exteíny [g02.111.570.060.270] kód histónový [g02.111.570.060.360] oblasť imunoglobulínov, variabilná `[g02.111.570.060.425]` miesta väzbové, protilátky [g02.111.570.060.425.079] oblasti určujúce komplementárnosť [g02.111.570.060.425.160] idiotypy imunoglobulínové [g02.111.570.060.425.580] inteíny [g02.111.570.060.440] knižnica peptidová [g02.111.570.060.620] signály triedenia proteínov [g02.111.570.060.670] + sekvencie aminokyselín, repetitívne [g02.111.570.060.720] +

subject heading

subject heading

Number of the records: 1

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.